Human Repeated Insult Patch Test

NCT ID: NCT03474874

Last Updated: 2019-07-16

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-26

Study Completion Date

2018-04-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Repeated insult patch test on healthy males and females to determine potential contact irritation or contact allergy in the skin

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermatitis Allergy Contact Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Collagen Dressing and Comparator

NeoMatriX Collagen Dressing and Comparators - positive control and normal saline will be applied to the absorbent pad portion of the exclusive dressing.

Group Type OTHER

NeoMatriX Collagen Dressing

Intervention Type DEVICE

Collagen wound dressing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NeoMatriX Collagen Dressing

Collagen wound dressing

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults;
* Subjects must understand and execute an Informed Consent Form that includes a HIPAA statement;
* Subjects must be considered dependable and able to follow directions

Exclusion Criteria

* Subjects who are in ill health;
* Subjects who are taking medications other than birth control;
* Female subjects who are pregnant (return positive urine pregnancy test), planning to become pregnant or lactating during the course of the trial;
* Subjects who have a history of adverse reactions to personal care products, or known sensitivity to the test materials or their constituents including patch materials;
* Subjects with any active skin disease;
* Subjects who have heavy alcohol consumption;
* Subjects with current use or history of repeated use of street drugs;
* Subjects with a significant past medical history to potentially effect results of study;
* Subjects with immunization less than 10 days prior to the test patch application;
Minimum Eligible Age

18 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NeXtGen Biologics, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Consumer Product Testing Company, Inc.

Fairfield, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NNAU01-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HRIPT for Collagen Dressing
NCT06283173 COMPLETED NA
18850 - Human Photoallergy Test
NCT02751463 COMPLETED NA
Metal Panel Allergen Patch Test Study
NCT04500834 UNKNOWN PHASE3
Dermal Cumulative Irritant Patch Study
NCT04064125 COMPLETED PHASE1
Human Comedogenicity Test
NCT03428997 COMPLETED NA
Neo-Synalar Modified 48 Hour Patch Test
NCT02168478 COMPLETED PHASE4